De novo complement-binding anti-hla antibodies in heart transplanted patients is associated with severe cardiac allograft vasculopathy and poor long-term survival

HIGHLIGHTS

• who: Guillaume Baudry et al. from the Centre d`Investigations Cliniques Plurithu00e9matique, Universitu00e9 de Lorraine, INSERM DCAC have published the article: De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival, in the Journal: (JOURNAL) of 26/05/2022
• what: The results of this study aim show, for the first time, the deleterious impact of complement-binding donor-specific a 7 of 10
• future: Although there is no prospective study showing the benefit associated with complement inhibition on long-term . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.